Cargando…
Mechanism of Action of Natural Dipeptidyl Peptidase-IV Inhibitors (Berberine and Mangiferin) in Experimentally Induced Diabetes with Metabolic Syndrome
BACKGROUND: Berberine (BER) and mangiferin are known natural dipeptidyl peptidase (DPP-IV) inhibitors. Hence, the study was designed to elucidate the mechanism of action of natural DPP-IV inhibitors (BER and MNG) in experimentally induced diabetes with metabolic syndrome. AIM: The aim of this study...
Autores principales: | Suman, Rajesh Kumar, Borde, Manjusha K, Mohanty, Ipseeta Ray, Singh, Hemant Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666829/ https://www.ncbi.nlm.nih.gov/pubmed/38023603 http://dx.doi.org/10.4103/ijabmr.ijabmr_115_23 |
Ejemplares similares
-
Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
por: Suman, Rajesh Kumar, et al.
Publicado: (2016) -
Antidiabetic activity of Commiphora mukul and Phyllanthus emblica and Computational analysis for the identification of active principles with dipeptidyl peptidase IV inhibitory activity
por: Mohanty, Ipseeta Ray, et al.
Publicado: (2021) -
Development of an Experimental Model of Diabetes Co-Existing with Metabolic Syndrome in Rats
por: Suman, Rajesh Kumar, et al.
Publicado: (2016) -
Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals
por: Davis, Joseph A., et al.
Publicado: (2010) -
Dipeptidyl peptidase-4 inhibitors: Novel mechanism of actions
por: Singh, Awadhesh Kumar
Publicado: (2014)